Form 4: Yield10 Bioscience VP Kristi Snell Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Kristi Snell, VP of Research and CSO at Yield10 Bioscience, reports a transaction involving common stock related to tax withholding upon RSU vesting.
Summary
- Kristi Snell, VP of Research and CSO at Yield10 Bioscience, filed a Form 4 detailing changes in beneficial ownership of the company's common stock.
- On August 15, 2024, 877 shares of common stock were disposed of to cover withholding taxes upon the partial vesting of Restricted Stock Units (RSUs).
- The transaction price was $1.5.
- Following the transaction, Snell directly owns 6,999 shares of common stock and indirectly owns 2,070 shares through a 401(k) plan.
- The share numbers reflect a 1:24 reverse stock split that occurred on May 2, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a small number of shares related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/02/2024 | 1:24 reverse stock split effected |
| 08/15/2024 | Date of transaction: Disposal of shares for tax withholding |
| 08/20/2024 | Date of Form 4 filing |
Keywords
Form 4, Yield10 Bioscience, Beneficial Ownership, Kristi Snell, Stock Transaction, RSU Vesting, YTEN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.